These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6434155

  • 1. The anxiogenic action of Ro 15-1788 is reversed by chronic, but not by acute, treatment with chlordiazepoxide.
    File SE, Pellow S.
    Brain Res; 1984 Sep 17; 310(1):154-6. PubMed ID: 6434155
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CGS 8216.
    File SE, Pellow S.
    Arch Int Pharmacodyn Ther; 1984 Oct 17; 271(2):198-205. PubMed ID: 6439138
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Behavioural effects of pentylenetetrazole reversed by chlordiazepoxide and enhanced by RO 15-1788.
    File SE.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun 17; 326(2):129-31. PubMed ID: 6433209
    [Abstract] [Full Text] [Related]

  • 6. The anxiogenic action of Ro 5-4864 is reversed by phenytoin.
    File SE, Lister RG.
    Neurosci Lett; 1983 Jan 31; 35(1):93-6. PubMed ID: 6682534
    [Abstract] [Full Text] [Related]

  • 7. Are the anxiogenic effects of yohimbine mediated by its action at benzodiazepine receptors?
    Pellow S, Chopin P, File SE.
    Neurosci Lett; 1985 Mar 22; 55(1):5-9. PubMed ID: 2986061
    [Abstract] [Full Text] [Related]

  • 8. A behavioral examination of convulsant benzodiazepine and GABA antagonist, Ro 5-3663, and benzodiazepine-receptor antagonist Ro 15-1788.
    Feldon J, Lerner T, Levin D, Myslobodsky M.
    Pharmacol Biochem Behav; 1983 Jul 22; 19(1):39-41. PubMed ID: 6413985
    [Abstract] [Full Text] [Related]

  • 9. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety.
    Baldwin HA, File SE.
    Psychopharmacology (Berl); 1989 Jul 22; 97(3):424-6. PubMed ID: 2497494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quinolines and anxiety: anxiogenic effects of CGS 8216 and partial anxiolytic profile of PK 9084.
    File SE, Lister RG.
    Pharmacol Biochem Behav; 1983 Feb 22; 18(2):185-8. PubMed ID: 6132404
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor.
    Baldwin HA, File SE.
    Brain Res Bull; 1988 May 22; 20(5):603-6. PubMed ID: 2838131
    [Abstract] [Full Text] [Related]

  • 14. Anxiogenic action of a convulsant benzodiazepine: reversal by chlordiazepoxide.
    File SE, Pellow S.
    Brain Res; 1983 Nov 14; 278(1-2):370-2. PubMed ID: 6685556
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The anxiolytic but not the sedative properties of tracazolate are reversed by the benzodiazepine receptor antagonist, Ro 15-1788.
    File SE, Pellow S.
    Neuropsychobiology; 1985 Nov 14; 14(4):193-7. PubMed ID: 2872613
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.